Canadians Prepare for 2021 Women Against MS Gala
This year’s Women Against Multiple Sclerosis (WAMS) Gala, which aims to raise funds for multiple sclerosis (MS) research, will…
Articles by Marisa Wexler, MS
Mono as Child or Teenager Tied to Risk of MS as Adult in Large Study
People who contract infectious mononucleosis — colloquially known as “mono” — during childhood or adolescence are at a roughly two…
Cold Eases Inflammation, Disease Severity in MS Mouse Model
Colder ambient temperatures may ease the inflammation that drives multiple sclerosis (MS), early research in a mouse model suggests.
Review: Racial Disparities Impact Black, Hispanic MS Patients in US
Black and Hispanic/Latinx people with multiple sclerosis (MS) in the U.S. tend to have more severe disease, but less…
#ECTRIMS2021 – CD20-positive T-cells May Be Early Drivers of MS
Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the virtual 37th Congress of the European Committee…
#ECTRIMS2021 – Nrg-1-treated Immune Cells Can Promote Myelin Repair
Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the virtual 37th Congress of the European…
#ECTRIMS2021 – Economic Burden of MS in US Exceeded $85B in 2019
Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the virtual 37th Congress of the European Committee…
#ECTRIMS2021 – Relapse-free Worsening More Likely in Late-onset MS
Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the virtual 37th Congress of the European…
#ECTRIMS2021 – Sativex Eases MS Patients’ Spasticity, Spasms in Trials
Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the virtual 37th Congress of the European…
#ECTRIMS2021 – Lower Relapse Rates Seen With Tysabri Than Ocrevus
Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the virtual 37th Congress of the European…
#ECTRIMS2021 – Brain Lesions Help Predict Long-term Disability
Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the virtual 37th Congress of the European…
#ECTRIMS2021 – Ponvory Effective in Early MS in OPTIMUM Trial
Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the virtual 37th Congress of the European…
#ECTRIMS2021 — Rituximab as First RRMS Therapy Outperforms Others
Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the virtual 37th Congress of the European…
Hydroxychloroquine Shows Potential to Treat PPMS in Phase 2 Trial
Treatment with hydroxychloroquine, an anti-malaria medication, appeared to help slow disability progression among people with primary-progressive multiple sclerosis (PPMS)…
#ECTRIMS2021 – Trial Analyses Support Evobrutinib for Relapsing MS
Treatment with evobrutinib, an experimental therapy for relapsing forms of multiple sclerosis (MS), reduced the size of inflammation-associated brain…
Study Finds Myc Gene Can Boost Efficiency of Myelin-repairing Cells
Increasing the activity of a gene called Myc can make oligodendrocyte precursor cells, or the cells that repair myelin, more…
Oct. 4 Online Conference Offers Latest Insights Into Progressive MS
An upcoming conference focused on progressive multiple sclerosis (MS) will offer the latest insights about the underlying biology of…
Cognitive Rehab ‘Effective, Low-risk’ in Treating Difficulties Due to MS
Cognitive rehabilitation is an effective therapy for cognitive problems brought on by multiple sclerosis (MS), a review study highlights.
Mesenchymal Stem Cells Show Promise in Preclinical Studies of MS
The therapeutic administration of mesenchymal stem cells can improve functional abilities and promote the restoration of lost myelin in rodent…
Cancer Researchers’ Discovery May Benefit MS Studies
In an unexpected discovery, scientists working to understand the biological underpinnings of brain tumors found that increasing the activity of…
Light-sensing Protein Could Explain Seasonal Changes in MS Risk
The presence of a light-sensing protein in the brain during the early stages of fetal development may help to explain…
Tecfidera May Reduce Relapse Rate More Than Other RRMS Therapies
First-line treatment with Tecfidera (dimethyl fumarate) leads to a lower rate of relapses in people with relapsing-remitting multiple…
MS Tied to Increased Risk After Colorectal Cancer Diagnosis
People who develop colon cancer are more likely to die in the first year, from that cancer or other causes,…
Anti-CD20 Therapies Show Similar Safety, Efficacy in RRMS
Anti-CD20 antibody therapies that target B-cells are highly effective for reducing the risk of relapses in people with relapsing-remitting…
Oral Fesoterodine Fumarate Can Ease Bladder Problems in MS
Treatment with fesoterodine fumarate — which comes as an extended-release tablet patients can take by mouth — can reduce bladder…
Vumerity Recommended for EU Approval as RRMS Treatment
A committee of the European Medicines Agency is recommending that Vumerity (diroximel fumarate) be approved as an…
Patients on Anti-CD20 Therapies Urged to Get COVID-19 Vaccine
While people with multiple sclerosis (MS) taking anti-CD20 therapies do not mount a robust antibody response after getting vaccinated…
Rim Lesions, Suggesting Chronic Inflammation, May Be Common
An imaging feature called a rim lesion is found in about 4 out of every 10 people with multiple…
Class of Molecules May Offer Opioid Alternative for Treating Pain
A class of molecules called positive allosteric modulators, or PAMs, may be useful in treating pain caused by nerve damage…
Chronic Inflammation in MS Linked to Specific Brain Cells in Study
An interaction between immune cells and glia cells in the brain, mediated by the C1q complement system protein, appears to…